HOUSTON, Feb. 3 /PRNewswire-FirstCall/ -- Cyberonics, Inc. today announced that the company will report financial results for the third quarter ended January 22, 2010 of its fiscal year ending April 30, 2010 on Wednesday, February 17, 2010 at 5:00 PM EST. The company will conduct a conference call to discuss those results on Thursday, February 18, 2010 at 9:00 AM EST.
About Cyberonics, Inc. and VNS Therapy(R)
Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.
Cyberonics, Inc.
